Filing Flows

Filing Flows › Comparisons › TLSI vs PROF

TriSalus Life Sciences vs Profound Medical: TLSI and PROF compared

TriSalus Life Sciences is the larger company: $11.4M of revenue in its latest quarter (Q2 2026) against $9.8M for Profound Medical (Q3 2026). Profound Medical is growing faster (+86% against +2% a year earlier). Profound Medical is more profitable, with an operating margin of -79.6% against -86.0%.

TriSalus Life Sciences vs Profound Medical, latest quarterTriSalus Life Sciences vs Profound Medical, latest quarterTriSalus Life Sciences (TLSI)Profound Medical (PROF)Revenue$11.4M$9.8MRevenue growth, Y/Y+2%+86%Operating margin-86.0%-79.6%Net margin-80.5%-78.6%

Where the money goes: TLSI and PROF

TriSalus Life Sciences (TLSI) · Q2 2026

TriSalus Life Sciences, Q2 2026: revenue $11.4M (+2% year over year), operating margin -86.0%, net loss $9.2M, operating cash flow −$10.1M. The chart follows the revenue to costs, profit and cash.

Profound Medical (PROF) · Q3 2026

Profound Medical, Q3 2026: revenue $9.8M (+86% year over year), operating margin -79.6%, net loss $7.7M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.

Profound Medical revenue by segment, Q3 2026Profound Medical revenue by segment, Q3 2026Capital equipment$5.7MRecurring - non-capital$4.1M
TriSalus Life Sciences (TLSI)Profound Medical (PROF)
Latest quarterQ2 2026Q3 2026
Revenue$11.4M$9.8M
Revenue growth, Y/Y+2%+86%
Operating margin-86.0%-79.6%
Net earnings−$9.2M−$7.7M
Net margin-80.5%-78.6%
Operating cash flow−$10.1M−$5.0M
Market value—$264M
Analysts’ mean target—$11.14

Where the revenue comes from

Profound Medical

Questions

Which is bigger, TriSalus Life Sciences or Profound Medical?

TriSalus Life Sciences is the larger company: $11.4M of revenue in its latest quarter (Q2 2026) against $9.8M for Profound Medical (Q3 2026).

Is TriSalus Life Sciences or Profound Medical growing faster?

Profound Medical is growing faster (+86% against +2% a year earlier).

Which is more profitable, TriSalus Life Sciences or Profound Medical?

Profound Medical is more profitable, with an operating margin of -79.6% against -86.0%.

More: TriSalus Life Sciences earnings · how TriSalus Life Sciences makes money · Profound Medical earnings · how Profound Medical makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.